Navigating the Complexities of Cancer Treatment-Induced Hypertension
Cancer therapy-induced hypertension (HTN) is an increasingly recognized complication associated with a wide range of anticancer agents, including vascular endothelial growth factor (VEGF) inhibitors, proteasome inhibitors, tyrosine kinase inhibitors, and alkylating agents. The pathogenesis of HTN in...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI AG
2025-06-01
|
| Schriftenreihe: | Journal of Cardiovascular Development and Disease |
| Schlagworte: | |
| Online-Zugang: | https://www.mdpi.com/2308-3425/12/6/235 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|